Chitosan-coated solid lipid nanoparticles for nose-to-brain drug delivery: A comprehensive review
Background: The blood-brain barrier (BBB) limits the effectiveness of treatment of several central nervous system (CNS) diseases, including Alzheimer's disease, Parkinson's disease, schizophrenia, and bipolar disorder. Because of this limitation, intranasal drug delivery is an effective, non-invasiv...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Creative Pharma Assent
2026-03-01
|
| Col·lecció: | Journal of Applied Pharmaceutical Research |
| Matèries: | |
| Accés en línia: | https://japtronline.com/index.php/joapr/article/view/2072 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|